Similar Articles
661 Liver transplantation for hepatocellular carcinoma: Where do we stand?
662 Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma
663 Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma
664 Mechanisms of hepatocellular carcinoma progression
665 Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma
666 Stereotactic body radiation therapy in patients with hepatocellular carcinoma: A mini-review
667 ADAMTS13 and von Willebrand factor are useful biomarkers for sorafenib treatment efficiency in patients with hepatocellular carcinoma
668 Role and mechanism of circ-PRKCI in hepatocellular carcinoma
669 Dual energy computed tomography for detection of metastatic lymph nodes in patients with hepatocellular carcinoma
670 MicroRNAs contribute to ATP-binding cassette transporter- and autophagy-mediated chemoresistance in hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA